The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Effect of Estrogen versus Testosterone on Circulating Osteoprotegerin and Other Cytokine Levels in Normal Elderly Men
Abstract
Recent studies have shown that estrogen (E) likely plays a dominant role in inhibiting bone resorption in normal elderly men. Because both E and T inhibit osteoclast development and activity, stimulate osteoclast apoptosis, and inhibit osteoblast production of IL-6, it is unclear why T is less potent than E in inhibiting bone resorption in vivo. Osteoprotegerin (OPG) binds to and inactivates RANKL, the final mediator of osteoclastogenesis. In vitro, OPG production is stimulated by E, and preliminary data suggest that T has the opposite effect. Thus, we analyzed serum for OPG levels from a study in which 59 elderly men (mean age, 68 yr) were made acutely hypogonadal using a GnRH agonist and were also placed on an aromatase inhibitor to block conversion of androgens to estrogens. They were studied first under conditions of physiologic E and T replacement, and then randomized to no replacement, replacement with E alone, T alone, or both E and T. E alone resulted in an 18.6 +/- 7.9% (mean +/- SEM) increase in serum OPG levels (P < 0.05), whereas T alone tended to decrease OPG levels (by 10.0 +/- 8.5%; P < 0.05 compared with E alone). Using a two-factor ANOVA model, there was a highly significant T effect (P = 0.006) on decreasing serum OPG levels. Serum TNF-alpha, IL-6, and IL-6 soluble receptor levels increased significantly in the men who had both E and T withdrawn, and the increases in TNF-alpha and IL-6sR were absent in the men treated with either E or T. However, due to the variability in these cytokine measurements, the ANOVA models were not significant for E or T effects. Taken together, these data suggest that in vivo, T decreases OPG levels, whereas E tends to have the opposite effect. These differential effects of E vs. T on OPG production may explain, at least in part, why T has weaker effects than E on inhibiting bone resorption in vivo in humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Testosterone replacement appeared to lower OPG levels in men made acutely hypogonadal by GnRH agonist and who also received aromatase inhibitor blockade of estrogen production (106).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [106]
In the citing paper
“elderly men with hypogonadism induced by gonadotrophin releasing hormone agonists developed a significant increase in serum TNFa and interleukin 6 compared with baseline.42”
From Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life (2004) · cites this paper as [42]
Citations
Cites
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Self-citationEstrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man
Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, B., Williams, T. C., Lubahn, D. B., & Korach, K. S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410203311604 · Cited by 2,471
Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B. F., Broxmeyer, H. E., & Manolagas, S. C. (1992) · Science · doi:10.1126/science.1621100 · Cited by 1,440
Morishima, A., Grumbach, M. M., Simpson, E. R., Fisher, C., & Qin, K. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.12.8530621 · Cited by 1,416
Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S.-I., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., et al. (1998) · Endocrinology · doi:10.1210/endo.139.3.5837 · Cited by 1,201
Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors
Kousteni, S., Bellido, T., Plotkin, L. I., O’Brien, C. A., Bodenner, D., Li, H., Han, K., Gregorio, G. B. D., Katzenellenbogen, J. A., Katzenellenbogen, B. S., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00268-9 · Cited by 1,163
Effect of testosterone and estradiol in a man with aromatase deficiency
Carani, C., Qin, K., Simoni, M., Faustini-Fustini, M., Serpente, S., Boyd, J., Korach, K. S., & Simpson, E. R. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707103370204 · Cited by 1,151
Estrogen promotes apoptosis of murine osteoclasts mediated by TGF–β
Hughes, D. E., Dai, A., Tiffee, J. C., Li, H. H., Mundy, G. R., & Boyce, B. F. (1996) · Nature Medicine · doi:10.1038/nm1096-1132 · Cited by 813
Falahati-Nini, A., Riggs, B. L., Atkinson, E. J., O’Fallon, W. M., Eastell, R., & Khosla, S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10942 · Cited by 757
Self-citationKousteni, S. (2001) · Cell · doi:10.1016/s0092-8674(02)08100-x · Cited by 757
Flagged first, then by citations
1 of the 32 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- Chen, 2001, Gender-independent induction of murine osteoclast apoptosis in vitro by either estrogen or non-aromatizable androgens, J Bone Miner Res, 16, S159
- Chen, 2000, Effects of 17β-estradiol (E2), genistein (GEN) and daidzein (DIZ) on osteoclastogenesis inhibitory factor (OCIF) and osteoclast differentiation factor (ODF) mRNA expressed during MC3T3–E1 cell differentiation, J Bone Miner Res, 15, S495
- Sarikaya, 2001, Serum osteoprotegerin levels in humans, J Bone Miner Res, 16, S215
- Riggs, 2001, Evidence that postmenopausal women with vertebral fractures due to type I osteoporosis have enhanced responsiveness of bone to estrogen deficiency, J Bone Miner Res, 16, S281
Cited by
Sorted by citations
Items 101–191 of 191
Ovariectomy increases RANKL protein expression in bone marrow adipocytes of C3H/HeJ mice
Beekman, K. M., Zwaagstra, M., Veldhuis‐Vlug, A. G., van Essen, H. W., den Heijer, M., Maas, M. M., Kerckhofs, G., Parac‐Vogt, T. N., Bisschop, P. H. L. T., & Bravenboer, N. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00142.2019 · Cited by 37
Estradiol and Inflammatory Markers in Older Men
Maggio, M. G., Ceda, G. P., Lauretani, F., Bandinelli, S., Metter, E. J., Artoni, A., Gatti, E., Ruggiero, C., Guralnik, J. M., Valenti, G., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0940 · Cited by 33
“Previous studies testing the relationship between E2 and IL-6 are limited to conditions of estrogen deficiency such as hypogonadism induced by GnRH agonists (25).”
BackgroundHormone treatment and muscle anabolism during aging: Androgens
Dillon, E. L., Durham, W. J., Urban, R. J., & Sheffield‐Moore, M. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2010.03.010 · Cited by 31
Androgen receptors and experimental bone loss — an in vivo and in vitro study
Steffens, J. P., Coimbra, L. S., Rossa, C., Kantarcı, A., Dyke, T. E. V., & Spolidório, L. C. (2015) · Bone · doi:10.1016/j.bone.2015.10.001 · Cited by 30
“Crosssectional and prospective studies suggest that low testosterone levels are related to increased serum sIL-6r in older men; however, there remains some controversy about the effect of IL-6 on testosterone [6, 7].”
BackgroundHernández, J. J. C., Almeida, M. D. G., Miralles, J. M., & Órfão, A. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.05.040 · Cited by 29
Gonadotropin‐releasing hormone analogues lead to pro‐inflammatory changes in T lymphocytes
Sung, N., Garcia, M. D. S., Dambaeva, S. V., Beaman, K. D., Gilman‐Sachs, A., & Kwak-Kim, J. Y.-H. (2016) · American Journal of Reproductive Immunology · doi:10.1111/aji.12522 · Cited by 28
Anastasilakis, A. D., Goulis, D. G., Pοlyzos, S. A., Gerou, S., Pavlidou, V., KOUKOULIS, G. N., & Avramidis, A. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0528 · Cited by 26
“In the studies where a change in OPG has been observed, measurements have often been made within a few days after initiation of treatment, before the changes in bone turnover have been established ( 19 ).”
BackgroundLi, C., Yang, L., Ren, X., Lin, M., Jiang, X., Shen, D., Xu, T., Ren, J., Huang, L., Qing, W., et al. (2019) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-019-01687-w · Cited by 26
Johnke, R. M., Edwards, J. M., Evans, M. J., Nangami, G. N., Bakken, N. T. G., Kilburn, J. M., Lee, T., Allison, R. R., Karlsson, U. L., & Arastu, H. H. (2009) · PubMed · Cited by 24
Lee, J. H., & Lee, S. W. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.04.070 · Cited by 23
Longitudinal Changes Over 10 Years in Free Testosterone Among HIV-Infected and HIV-Uninfected Men
Slama, L., Jacobson, L. P., Li, X., Palella, F. J., Margolick, J. B., Kingsley, L., Wiley, D. J., Pialoux, G., Dobs, A. S., & Brown, T. T. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000821 · Cited by 23
Martin, A., Yu, J., Xiong, J., Khalid, A. B., Katzenellenbogen, B. S., Kim, S. H., Katzenellenbogen, J. A., Malaivijitnond, S., Gabet, Y., Krum, S. A., et al. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25862 · Cited by 24
“While estrogen-mediated OPG stimulation may contribute to inhibition of bone resorption, such a mechanism is not employed by androgens (Hofbauer, Hicok, Chen, & Khosla, 2002; Khosla et al., 2002).”
BackgroundHaghighatdoost, F., & Gh, B. F. N. M. (2017) · European Journal of Clinical Nutrition · doi:10.1038/s41430-017-0048-z · Cited by 23
“Another study demonstrated that the induction of hypogonadism in males leads to increased serum levels of IL-6 and sIL-6r [74].”
BackgroundŽiaran, S., Gonçalves, F., & Breza, J., Jr. (2012) · World Journal of Urology · doi:10.1007/s00345-012-0926-x · Cited by 22
“In one study, acute induction of hypogonadism with GnRH agonists in healthy elderly men was followed by elevated serum levels of inflammatory cytokines TNF alpha and IL-1 beta, suggesting an antiinflammatory role for testosterone [26].”
BackgroundTestosterone, SHBG and differential white blood cell count in middle-aged and older men
Brand, J. S., van der Schouw, Y. T., Dowsett, M., Folkerd, E. J., Luben, R., Wareham, N. J., & Khaw, K. (2012) · Maturitas · doi:10.1016/j.maturitas.2011.12.007 · Cited by 22
Serum osteoprotegerin concentrations are decreased in women with the polycystic ovary syndrome
Escobar-Morreale, H. F., Botella-Carretero, J. I., Martínez-García, M. Á., Luque‐Ramírez, M., Álvarez‐Blasco, F., & Millán, J. L. S. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0107 · Cited by 21
“of the involved factors in its reduction ( 47 , 48).”
BackgroundHarding, G., Mak, Y. T., Evans, B. A. J., Cheung, J., MacDonald, D., & Hampson, G. (2006) · Cytokine · doi:10.1016/j.cyto.2006.10.012 · Cited by 20
Osteoporosis: From osteoscience to neuroscience and beyond
Kwan, P. (2015) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2015.02.001 · Cited by 20
Bone Physiology: Bone Cells, Modeling, and Remodeling
Dempster, D. W., & Raisz, L. G. (2014) · Springer eBooks · doi:10.1007/978-1-4939-2001-3_3 · Cited by 19
“Estrogen may inhibit resorption by altering the production of cytokines in marrow cells, increasing OPG production or inducing osteoclast apoptosis, possibly by increasing TGFβ [ 23 , 82 – 84 ].”
BackgroundA new regulator of osteoclastogenesis: Estrogen response element–binding protein in bone
Chen, H., Gilbert, L. C., Lu, X., Liu, Z., You, S., Weitzmann, M. N., Nanes, M. S., & Adams, J. S. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.456 · Cited by 19
“Loss of estrogen action via its genomic and nongenomic signal pathways activates a complex cascade in which elevated inflammatory cytokines modulate expression of the receptor activator of nuclear factor kB ligand (RANKL) and its soluble decoy protein, osteoprotegerin (OPG).((15,16)) RANKL is expressed as a membranebo…”
BackgroundScafonas, A., Reszka, A. A., Kimmel, D. B., Hou, X., Su, Q., Birzin, E. T., Kim, S., Chen, H. Y., Tan, Q., Roher, S. P., et al. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.10.013 · Cited by 17
Osteoclast: Origin and Differentiation
Rubin, J. E., & Greenfield, E. M. (2005) · Springer eBooks · doi:10.1007/1-84628-016-8_1 · Cited by 18
“This suggests a response to an upregulated resorptive system [79].”
BackgroundAmer, O. E., Wani, K., Ansari, M. G. A., Alnaami, A. M., Aljohani, N., Abdi, S., Hussain, S. D., Al‐Daghri, N. M., & Alokail, M. S. (2022) · Medicina · doi:10.3390/medicina58080976 · Cited by 17
“The in vitro stimulation of OPG biosynthesis in osteoblasts cell lineage by estrogen gives great evidence for the contribution of the RANKL/RANK/OPG system in the sex steroid hormones bone-sparing effects [43–46] as well as in human subjects [46].”
Effects of Transdermal Testosterone Tretment on Inflammatory Markers in Elderly Males
Maggio, M. G., Snyder, P. J., Vita, F. D., Ceda, G. P., Milaneschi, Y., Lauretani, F., Luci, M., Cattabiani, C., Peachey, H., Valenti, G., et al. (2014) · Endocrine Practice · doi:10.4158/ep13357.or · Cited by 16
Kananen, K., Volin, L., Laitinen, K., Ruutu, T., & Välimäki, M. (2005) · Osteoporosis International · doi:10.1007/s00198-005-0040-7 · Cited by 16
“In a study of elderly men oestrogen substitution increased, but testosterone replacement decreased serum OPG levels [34].”
BackgroundSex Dimorphism in Muscle Damage–induced Inflammation
Luk, H., Levitt, D. E., Appell, C. R., & Vingren, J. L. (2021) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002628 · Cited by 15
Glycitein decreases the generation of murine osteoclasts and increases apoptosis
Winzer, M., Rauner, M., & Pietschmann, P. (2010) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-010-0811-4 · Cited by 15
Nagasaka, H., Yorifuji, T., Kosugiyama, K., Egawa, H., Kawai, M., Murayama, K., Hasegawa, M., Sumazaki, R., Tsubaki, J., Kikuta, H., et al. (2004) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200410000-00018 · Cited by 14
Sahbani, K., Cardozo, C. P., Bauman, W. A., & Tawfeek, H. A. W. (2021) · Endocrinology · doi:10.1210/endocr/bqab230 · Cited by 15
Testicular and blood steroid levels in aged men.
Carreau, S., Bourguiba, S., & Marie, E. (2004) · PubMed · Cited by 13
Starlinger, J., Kaiser, G., Thomas, A., & Sarahrudi, K. (2019) · Bone and Joint Research · doi:10.1302/2046-3758.87.bjr-2018-0116.r3 · Cited by 14
Phan, Q. T., Chua, K. Y., Jin, A., Winkler, C., & Koh, W. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4646 · Cited by 12
“activities of osteoclasts, leading to higher rates of bone turnover and increased incidence of fractures in older adults.((1-4)) Hence,”
BackgroundIdiopathic or Hypogonadal Osteoporosis in Men
Ebeling, P. R. (2004) · Treatments in Endocrinology · doi:10.2165/00024677-200403060-00006 · Cited by 12
HIV and Bone Disease: A Perspective of the Role of microRNAs in Bone Biology upon HIV Infection
Carpio‐Cano, F. E. D., Cadena, R. A. D., & Sawaya, B. E. (2013) · Journal of Osteoporosis · doi:10.1155/2013/571418 · Cited by 11
“Their signaling transduction is through both canonical Smad-dependent pathways (TGF-𝛽/BMP ligands, receptors, and Smads) and noncanonical Smadindependent signaling pathways (e.g., p38 mitogen-activated protein kinase pathway, MAPK).”
BackgroundÉva, K.-J., Pethő, Z., Pap, Z. V., Kalina, E., Földesi, R., Balogh, Á. L., Antal‐Szalmás, P., & Bhattoa, H. P. (2015) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-015-0684-1 · Cited by 10
“was demonstrated in vivo that testosterone therapy resulted in lower OPG levels [9].”
BackgroundThe Impact of Sex Hormone Changes on Bone Mineral Deficit in Chronic Renal Failure
Doumouchtsis, K., Perrea, D. N., & Doumouchtsis, S. K. (2009) · Endocrine Research · doi:10.1080/07435800903127598 · Cited by 12
Kalyanaraman, H., China, S. P., Casteel, D. E., & Pilz, R. B. (2025) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2025.01.007 · Cited by 10
Bellissimo, C. J., Ribeiro, T. A., Yeo, E., Jazwiec, P. A., Luo, H., Bains, J., Kennedy, K. M., Bowdish, D. M. E., & Sloboda, D. M. (2025) · Biology of Reproduction · doi:10.1093/biolre/ioaf143 · Cited by 10
“This included lower expression of Secreted phosphoprotein 1 (SPP-1) and Osteoprotegerin (OPG; Figure 4b), which are suppressed by androgen signaling in other contexts [78, 79], highlighting the ability of this assay to detect biologically relevant differences.”
Metastasin S100A4 Is a Mediator of Sex Hormone-Dependent Formation of the Cortical Bone
Erlandsson, M. C., Li, B., Jonsson, I., Andersson, K., & Bokarewa, M. I. (2013) · Molecular Endocrinology · doi:10.1210/me.2012-1398 · Cited by 9
“The aromatization of T into 17 -estradiol and the activation of ERs are presently considered a mechanism responsible for most of the androgen-related effects on bone (6).”
BackgroundLiu, P. Y., Hoey, K. A., Mielke, K. L., Veldhuis, J. D., & Khosla, S. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1583 · Cited by 9
Self-citationRole of sex steroids in the regulation of bone metabolism in the adult skeleton
Kaufman, J.-M. (2006) · Annales d Endocrinologie · doi:10.1016/s0003-4266(06)72565-3 · Cited by 8
“Osteoprotegerin levels have been reported to be positively associated with E2 levels and negatively correlated to markers of bone resorption [21, 43].”
BackgroundPepene, C. E., Crişan, N., & Coman, I. (2011) · Clinical and investigative medicine · doi:10.25011/cim.v34i4.15365 · Cited by 9
“In gonadotropin releasing hormone-induced male hypogonadism, testosterone replacement therapy signi cantly decreased serum OPG levels [9] while low serum OPG was observed in women with polycystic ovary syndrome [10], a disorder characterized by hyperandrogenemia.”
BackgroundMohammadrezaei, A., Ardekani, A. M., Farhangi, M. A., Abbasi, M. M., & Mousavi, R. (2023) · Nutrition and Metabolic Insights · doi:10.1177/11786388231155006 · Cited by 8
Chapter 20. Age‐Related Bone Loss
Kiel, D. P., Rosen, C. J., & Dempster, D. W. (2008) · Primer on the metabolic bone diseases and disorders of mineral metabolism · doi:10.1002/9780470623992.ch20 · Cited by 8
Regulación del proceso de remodelado óseo
García, R. R., Moreno, P. R., & Muñoz‐Torres, M. (2008) · Revista Española de Enfermedades Metabólicas Óseas · doi:10.1016/s1132-8460(08)71132-2 · Cited by 8
Nanes, M. S., & Pacifici, R. (2005) · Springer eBooks · doi:10.1007/1-84628-016-8_5 · Cited by 7
Nutrition and Bone Health in the Elderly
Rosen, C. J. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-740-6_13 · Cited by 6
Serum Osteoprotegerin and Sex Steroid Levels in Patients With Prostate Cancer
Varsavsky, M., Reyes‐García, R., Perez, M. D., Ramírez, A. R. G., Mijan, J. L., & Muñoz‐Torres, M. (2012) · Journal of Andrology · doi:10.2164/jandrol.111.014696 · Cited by 6
Fichna, M., Żurawek, M., Fichna, P., Gryczyńska, M., Nowak, J., & Ruchała, M. (2012) · PubMed · Cited by 6
Anwar, M. J., Alenezi, S. K., Mahmood, D., Azam, F., & Alharbi, K. S. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174313 · Cited by 6
Nagasaka, H., Yorifuji, T., Kosugiyama, K., Egawa, H., Kawai, M., Murayama, K., Hasegawa, M., Sumazaki, R., Tsubaki, J., Kikuta, H., et al. (2004) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.2004.tb00874.x · Cited by 6
Testosterone and cardiovascular disease
Channer, K. S., & Jones, T. H. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003353.011 · Cited by 5
The Role of the Immune System in the Development of Osteoporosis
Mödder, U. I., Riggs, B. L., & Khosla, S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375670-1.10009-3 · Cited by 4
Self-citationPutative Effects of Sex Hormones on Urinary Tract Infection
Brachtlová, T., Gardlík, R., & Tóthová, Ľ. (2017) · Folia Biologica · doi:10.14712/fb2017063020035 · Cited by 4
“Other studies showed that TST replacement therapy in elderly or hypogonadal males decreased TNF-α, IL-6 and increased IL-10 production (Khosla et al., 2002; Malkin et al., 2004).”
ResultBiology, Physiology, and Morphology of Bone
Rubin, J. E., & Rubin, C. T. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3285-4.10004-x · Cited by 4
Karasu, Y. Ö., Orbak, R., Kaşalı, K., Berker, E., & Kantarcı, A. (2023) · Clinical Oral Investigations · doi:10.1007/s00784-023-05211-y · Cited by 3
Influence of sex and estrogen on vitamin D‐induced arterial calcification in rats
Nakamura, T., Akishita, M., Kozaki, K., Toba, K., Orimo, H., & Ouchi, Y. (2003) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1046/j.1444-1586.2003.00077.x · Cited by 3
Aging and the Cardiovascular System
Marı́n-Garcı́a, J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-404599-6.00021-4 · Cited by 3
Hofbauer, L. C., Allolio, B., & Arlt, W. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.8.8706 · Cited by 3
“In their elegant study, men were rendered acutely hypogonadal using a GnRH agonist and treated with an aromatase inhibitor to block conversion of androgens to estrogens, before receiving 17 -estradiol alone, testosterone alone, or both 17 -estradiol and testosterone, to distinguish the differential effects of androgen…”
BackgroundMethodInfluentialEnvejecimiento músculo-esquelético
Martínez, J. M. O., García, J. M., & Macías, J. G. (2007) · Revista Española de Enfermedades Metabólicas Óseas · doi:10.1016/s1132-8460(07)73495-5 · Cited by 2
Tae, H. J., Baek, K., Oh, E.-S., Oh, K. W., Lee, W., Kim, H.-S., Han, J.-H., Cha, B. Y., Lee, K. W., Son, H., et al. (2005) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2005.20.1.40 · Cited by 1
“인체에서의 연구는 부족한 상태이며, 최근 정상 성인 에서 혈중 OPG 농도를 측정하여 골밀도 및 골대사와 의 상관성에 대해 보고된 바 있으나[25,26] 이식 직후 골소실이 뚜렷이 발생하는 조혈모세포이식 후의 RANKL와 OPG 변화 및 그 임상적 의의에 대해서는 알 려진 바가 없다.”
Adiponectin as Biomarker of Osteoporosis
Lubkowska, A., Radecka, A., & Mieszkowski, J. (2015) · Exposure and Health · doi:10.1007/978-94-007-7745-3_9-1 · Cited by 2
Lu, Y., Wang, W., Yang, B., Cao, G., Du, Y., & Liu, J. (2024) · Indian Journal of Orthopaedics · doi:10.1007/s43465-024-01152-0 · Cited by 2
“Their therapeutic potential for various diseases has been widely studied [13–18].”
Nutrition and bone health in the elderly
Cederholm, T. (2009) · Elsevier eBooks · doi:10.1533/9781845695484.2.252 · Cited by 2
Raisz, L. G. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-740-6_3 · Cited by 1
Guglielmi, G., Diano, D., Ponti, F., Nasuto, M., & Bazzocchi, A. (2013) · Springer eBooks · doi:10.1007/978-3-642-35579-0_3 · Cited by 1
Estrogen-dependent Bone Loss and Osteoporosis
Lindsay, R. S., & Cosman, F. (2003) · doi:10.1007/978-1-4757-4561-0_9 · Cited by 1
Adiponectin as Biomarker of Osteoporosis
Lubkowska, A., Radecka, A., & Mieszkowski, J. (2017) · Biomarkers in disease · doi:10.1007/978-94-007-7693-7_9 · Cited by 1
Pekkinen, M. (2008) · Työväentutkimus Vuosikirja · Cited by 1
Ockrim, J., Lalani, E., & Abel, P. D. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000159531.57786.ae · Cited by 1
Endocrinological Aspects of Atherosclerosis
Freudenberger, T., & Fischer, J. W. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0338-8_28
Anti-Aging Medicine LiteratureWatch
(2002) · Rejuvenation Research · doi:10.1089/109454502321091509
Mahamadou, A. N. L. (2018) · theses.fr (ABES) · doi:10.70675/e3a8c8b3z1d51z4ae0z8830z7b911248b588
“39 régulateur important du métabolisme osseux, dont l’action est de limiter la résorption ostéoclastique [30].”
Desarrollo normal del esqueleto y regulación de la formación y reabsorción óseas
Moreno, P. R., Reyes‐García, R., & Martín, A. G. (2014) · Elsevier eBooks · doi:10.1016/b978-84-9022-503-5.00001-0 · Cited by 1
Estudio del metabolismo mineral óseo en el cáncer de próstata avanzado
Flores, S. Q. (2011) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Osteoporosis and Vascular Calcification: Lesson from OPG KO Mice
Kim, N. (2005) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2005.20.6.571
“혈청 내 OPG 양과 성호르 몬의 양 사이에 연관이 제시되었는데, 혈청 내 OPG 양이 남자 보다 여자에게 더 많고, 폐경기후 여성에게서 감소하며, 에스트 로겐 대체 요법 및 경구용 피임제에 의해 증가함 등의 결과가 밝 혀졌다[107,159,160,191,192].”
Deveci, K., Gökakın, A. K., Boztosun, A., Devecı, H., Senel, S., Uslu, A. U., & Sancakdar, E. (2013) · PubMed
García, D. F. (2011) · Institutional Repository of the University of Granada (University of Granada)
Testosterone and frailty in elderly men
Emmelot‐Vonk, M. H. (2009) · Utrecht University Repository (Utrecht University)
Marı́n-Garcı́a, J., Goldenthal, M. J., & Moe, G. W. P. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-74072-0_16
INFLUENCE OF TNF ALPHA ON TESTOSTERONE INDUCED CARDIAC EFFECTS IN ISOLATED FROG HEART MODEL
Raja, A. K., Babu, A. V., Kumar, R., Fx, M., Shah, N., & Tyagi, M. G. (2009) · DOAJ (DOAJ: Directory of Open Access Journals)
Miller‐Kasprzak, E., Pupek‐Musialik, D., & Jabłecka, A. (2010)
[Acquired androgen deficiency in men with chronic cardiac failure].
Vm, P., Kravchenko, A. Y., & Semenova, E. A. (2012) · PubMed
Functional characterisation of an osteoclast-derived osteoblastic factor (ODOF)
Phan, T. A. (2004) · UWA Profiles and Research Repository (UWA)
Frailty and anabolic hormones in ageing men
O’Connell, M. D. L. (2011) · Research Explorer (The University of Manchester)
Osteoporose bei/durch Adipositas – Schutz oder Risiko?
Schober, H., Kasch, K., & Schröder, G. (2022) · Osteologie/Osteology · doi:10.1055/a-1909-0144
Systemic medications and implant success
Sukumaran, P., Dionysius, D. D., Ngeow, W. C., Tan, C. C., & Hussin, M. Z. (2022) · Journal of Dental Implants · doi:10.4103/jdi.jdi_23_21
The Role of Androgens and Estrogens in the Male Skeleton
Khosla, S., & Bilezikian, J. P. (2004) · Principles of Gender-Specific Medicine · doi:10.1016/b978-012440905-7/50368-6
Self-citationPharmacotherapy Options in Cancer Treatment-induced Bone Loss: Focus on Bisphosphonates
Ito, K. (2009) · Clinical Medicine Therapeutics · doi:10.4137/cmt.s2064
Alhosseini, R., Aghaie, M., Ghorbani, S., Mohammadi, Z., & Khajeniazi, S. (2026) · BMC Research Notes · doi:10.1186/s13104-026-07811-9
Metadata
- Authors
- Khosla, S., Atkinson, E. J., Dunstan, C. R., & O’Fallon, W. M.
- Affiliations
- Mayo Clinic (US)
- Amgen (United States) (US)
- Corresponding author
- Khosla, Sundeep
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2002-04-01
- Volume
- 87
- Issue
- 4
- Pages
- 1550-1554
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2124998345
- Cited by
- 191
- References
- 32
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 4 · 2021: 4 · 2020: 3 · 2019: 4 · 2018: 2 · 2017: 5 · 2016: 4 · 2015: 7 · 2014: 7 · 2013: 8 · 2012: 13
- FWCI
- 7.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG 04875, P01AG004875)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- estrogen, testosterone, osteoprotegerin, bone resorption, older men, aromatase inhibitors, hormone replacement therapy, cytokines, TNF-α, interleukin-6, soluble IL-6 receptor, RANKL, osteoclastogenesis, bone metabolism
- MeSH terms
- Aged, Aged, 80 and over, Bone Resorption, Estrogens, Glycoproteins, Humans, Male, Reference Values, Gonadal Steroid Hormones, Testosterone, Biomarkers, Cytokines, Receptors, Tumor Necrosis Factor, Receptors, Cytoplasmic and Nuclear, Osteoprotegerin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
